<DOC>
	<DOCNO>NCT00100555</DOCNO>
	<brief_summary>The purpose trial study clinical safety , tolerability , efficacy zoledronic acid compare oral bisphosphonate postmenopausal woman osteoporosis .</brief_summary>
	<brief_title>A Study Clinical Safety , Tolerability , Efficacy Zoledronic Acid Compared Oral Bisphosphonate</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Zoledronic acid</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>Postmenopausal woman 45 79 year age Must osteopenic/osteoporotic Any woman childbearing potential Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Osteoporosis , osteopenia , post-menopausal , zoledronic acid</keyword>
</DOC>